Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors.
about
PRA1 promotes the intracellular trafficking and NF-kappaB signaling of EBV latent membrane protein 1BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathwayIdentification of transmembrane protein 134 as a novel LMP1-binding protein by using bimolecular fluorescence complementation and an enhanced retroviral mutagenInhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organizationSpecific association of glycoprotein B with lipid rafts during herpes simplex virus entryActivation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane proteinHepatitis C Virus RNA Replication Occurs on a Detergent-Resistant Membrane That Cofractionates with Caveolin-2Epstein-Barr virus latent genesPalmitoylation of KChIP splicing variants is required for efficient cell surface expression of Kv4.3 channelsLipid rafts and B-cell activation.Dynamic palmitoylation and the role of DHHC proteins in T cell activation and anergy.C-terminal domain of the Epstein-Barr virus LMP2A membrane protein contains a clustering signalIn nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell linesLMP1 strain variants: biological and molecular properties.LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activationSubversion of B lymphocyte signaling by infectious agents.Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling.LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaBRespiratory syncytial virus F envelope protein associates with lipid rafts without a requirement for other virus proteins.The B subunit of Escherichia coli enterotoxin helps control the in vivo growth of solid tumors expressing the Epstein-Barr virus latent membrane protein 2A.Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stabilityOncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis.Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12(I) protein of human T-cell leukemia/lymphoma virus type 1.HMG CoA reductase inhibitors (statins) to treat Epstein-Barr virus-driven lymphomaA novel recombinant variant of latent membrane protein 1 from Epstein Barr virus in Argentina denotes phylogeographical association.Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signalingRole of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection.Viral modulation of T-cell receptor signalingEpstein-Barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformationNuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.Cholesterol dependence of HTLV-I infection.Simvastatin induces apoptosis of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and delays development of EBV lymphomas.LMP2A does not require palmitoylation to localize to buoyant complexes or for function.High molecular weight complex analysis of Epstein-Barr virus Latent Membrane Protein 1 (LMP-1): structural insights into LMP-1's homo-oligomerization and lipid raft associationAberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomas.Characterization of the latent membrane protein 1 signaling complex of Epstein-Barr virus in the membrane of mammalian cells with bimolecular fluorescence complementation.Upregulation of Caveolin-1 correlate with Akt expression and poor prognosis in NPC patients.
P2860
Q24300115-1389D9E1-FF0B-48AD-A059-5C57774FACFEQ24537608-107757C5-F518-4E57-A4BA-C2228B1A05D9Q24633907-08D5ECD2-444D-46D8-B531-89C7B27362EAQ24647417-6F72A689-E9EE-46D1-AFE7-08E3243742C8Q24683262-C55E2DDA-E27D-40C9-A931-F3B6CC16DF60Q24683297-E6AD784A-03A9-410A-8332-E50E4E00749EQ27473377-73656595-AB0D-4059-850E-E7C8DB0C6267Q28082701-89271EBB-186E-4C8E-ABD3-DC8CF37A763BQ28217210-F14592AB-4FE5-4232-AEAE-BE5D58C93F5EQ33337033-814285E9-D27B-46B4-A3AD-7E65233A79DEQ33779818-1488327B-CF46-40A2-A231-BB2A7D8FA02CQ33849076-BF563AF5-56ED-4679-8B96-C84F3F5AE2A1Q34092709-5412BFF0-2DFD-4682-96EC-2C0A288F0E4FQ34270437-BC849C38-E3C5-4D64-896C-F3B21B531684Q34327176-8F90CE07-2A6D-4585-84FE-E8832DEFCA61Q34717145-13AC8358-2335-4E77-A37F-60D4010F60A0Q35052575-5291FBE5-4C22-4FA4-9955-E3B7EDF10A88Q35078625-2DC7FF60-52AE-4778-B650-6E116A306ED9Q35121711-62BBADF0-E3B0-4A75-9085-900524861D90Q35122447-486F0440-949F-4F3F-B8EA-8F5C6B1BCE71Q35139273-1954EF92-1144-4774-9016-B50C0B20EC0BQ35185963-1B89837F-E56D-4A1F-BB58-87489850CE3CQ35236817-88BD5CF0-8EA0-4705-B459-AE74AD5624D2Q35793738-8AC3A1B7-2383-4BF7-B46D-E368DDFD4E4BQ35841060-401AAFB5-B2E0-497E-94B8-71B88D8C1AC2Q35947986-A18DB2C6-E72F-45DF-AD27-4FC7F2BAFA94Q36108705-1A864AD6-CFEB-4290-BBDD-B52A992ADDDFQ36318425-5DFFBD06-074C-4FB6-8630-77F7B20B7F54Q36371153-FEE0ADD0-6FB0-4A40-9404-B91B9B3DA041Q36459268-80497042-83AA-48C2-9BCD-233910D434F2Q36540182-0E8BB017-D155-4724-8D08-FA7737C46C87Q36559750-3410276D-BEA7-4C30-8CE7-D7668139B145Q36961875-20656351-110F-47C7-AB4D-55D08C8A5D4CQ37163395-2CD77FCF-34B0-4F6D-89B2-71E7D804E40BQ37415623-8382E250-08FE-440D-87C2-587B97A596C4Q37567931-00441258-AD22-418E-9947-592E9585B5BBQ37587096-C05156B7-8021-4690-80E9-73BA5FF3B76BQ37708916-A27A3228-14E2-42DA-9D91-672ED3674788Q38427527-BA4D1E6F-E192-4A21-93CF-D4EE9F51A58DQ38886693-972CFDBE-7950-4AE1-A905-2AB568A2454C
P2860
Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Epstein-Barr virus latent-infe ...... receptor cytoplasmic factors.
@ast
Epstein-Barr virus latent-infe ...... receptor cytoplasmic factors.
@en
type
label
Epstein-Barr virus latent-infe ...... receptor cytoplasmic factors.
@ast
Epstein-Barr virus latent-infe ...... receptor cytoplasmic factors.
@en
prefLabel
Epstein-Barr virus latent-infe ...... receptor cytoplasmic factors.
@ast
Epstein-Barr virus latent-infe ...... receptor cytoplasmic factors.
@en
P2860
P356
P1476
Epstein-Barr virus latent-infe ...... receptor cytoplasmic factors.
@en
P2093
P2860
P304
P356
10.1073/PNAS.081075298
P407
P577
2001-04-01T00:00:00Z